3610 – Anti-GPC
• Use of porcine H+/K+ ATPase
• Ready-to-use (exception: wash buffer) and barcoded reagents
• Quality assured handling in routine laboratories
• Short incubation times (60 min / 30 min / 15 min) at room temperature
• Quantitative determination of IgG antibodies
• Calibrated by use of an internal reference sample
• Results expressed in U/mL
• Excellent diagnostic sensitivity and specificity
• High precision within the measurement range
• CE marked
The Anti-GPC is a quantitative immunoassay for the determination of IgG antibodies against gastric parietal cells of the gastric mucosa (GPC) in human serum. The Anti-GPC is intended as an aid in the diagnosis of pernicious anemia and type A gastritis in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
Pernicious anemia (Biermer‘s disease) is based on an undersupply of vitamin B12, which in turn can be due to a lack of intrinsic factor. Vitamin B12 and the Intrinsic Factor Vitamin B12 is essential for the formation of blood cells. It is formed by microorganisms, ingested with food, released in the stomach by proteolytic processes and bound to intrinsic factor (IF). The intrinsic factor is a glycoprotein produced in the parietal cells of the gastric mucosa. It protects the vitamin from decomposition and is used for its absorption in the small intestine. A lack of intrinsic factor can lead to an undersupply of vitamin B12 and thus to pernicious anemia.
Type A gastritis is a chronic autoimmune disease in which antibodies against parietal cells and intrinsic factor attack the gastric mucosa. The destruction of the parietal cells leads to a reduced absorption of vitamin B12 and thus to its undersupply due to a lack of intrinsic factor. Genetic causes, the surgical removal of a section of the stomach and chronic inflammation of the gastric mucosa can also result in a lack of intrinsic factor. A lack of vitamin B12 can also be triggered by medication or a diet that is too one-sided and therefore unbalanced.
Typical symptoms of pernicious anemia are fatigue, increased heart rate and paleness as a result of the anemia. Indigestion and abdominal pain also occur. Neurological symptoms such as numbness in the hands and feet, unsteady gait, coordination disorders or paralysis often occur without signs of anemia. Visual disturbances or the picture of a polyneuropathy are also possible. Poor concentration, depression and psychoses, schizophrenia and dementia have also been described. Pernicious anemia can progress to funicular myelosis.
The diagnosis of pernicious anemia is based on the clinical symptoms and a large number of laboratory diagnostic tests. To detect an autoimmune disease, antibodies against parietal cells, against the H+/K+ ATPase of the stomach and against the intrinsic factor are determined.
|Indication||Pernicious anemia and type A gastritis|
|Description||Enzyme immunoassay for the quantitative determination of IgG antibodies against gastric parietal cells in human serum|
|Format||Microtiter plate coated with porcine H+/K+-ATPase (α- und β subunit)|
|Total incubation time||105 min.|
|Sample volume||10 µL serum|
|No. of determinations||96 (89 x 1) + 5 x Calibrators and 2 x Controls|